The estimated Net Worth of Mary Z.Zhang Jack Y. Luo is at least $72.7 millió dollars as of 10 January 2024. Mary Luo owns over 131,386 units of Amphastar Pharmaceuticals Inc stock worth over $49,776,029 and over the last few years he sold AMPH stock worth over $19,971,316. In addition, he makes $2,976,100 as Chief Operating Officer és Chief Scientist and Chairman of the Board at Amphastar Pharmaceuticals Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mary Luo AMPH stock SEC Form 4 insiders trading
Mary has made over 2 trades of the Amphastar Pharmaceuticals Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 131,386 units of AMPH stock worth $7,172,362 on 10 January 2024.
The largest trade he's ever made was selling 219,800 units of Amphastar Pharmaceuticals Inc stock on 8 January 2024 worth over $12,798,954. On average, Mary trades about 175,593 units every 1 days since 2024. As of 10 January 2024 he still owns at least 1,104,416 units of Amphastar Pharmaceuticals Inc stock.
You can see the complete history of Mary Luo stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mary Luo biography
Dr. Mary Ziping Luo Ph.D. serves as Chief Operating Officer, Chief Scientist and Chairman of the Board of the Company. Dr. Luo co-founded our company in 1996 and has served as our Chief Operating Officer and chairman of our board of directors since our inception and as Secretary from 1997 to April 2004. Dr. Luo has also served as our Chief Scientist since 2005. Dr. Luo co-founded Applied Physics & Chemistry Laboratories, Inc., or APCL, a full service chemical analytical laboratory, in May 1989, where she held the position of Chief Operating Officer. Dr. Luo is a professor emeritus of chemistry at California State Polytechnic University, Pomona and is named as the inventor on several U.S. and foreign patents. Dr. Luo received a Ph.D. in chemistry from Princeton University and was a Post Doctoral Research Associate at the California Institute of Technology.
What is the salary of Mary Luo?
As the Chief Operating Officer és Chief Scientist and Chairman of the Board of Amphastar Pharmaceuticals Inc, the total compensation of Mary Luo at Amphastar Pharmaceuticals Inc is $2,976,100. There are 1 executives at Amphastar Pharmaceuticals Inc getting paid more, with Jack Zhang having the highest compensation of $5,969,740.
How old is Mary Luo?
Mary Luo is 70, he's been the Chief Operating Officer és Chief Scientist and Chairman of the Board of Amphastar Pharmaceuticals Inc since 2005. There are 6 older and 10 younger executives at Amphastar Pharmaceuticals Inc. The oldest executive at Amphastar Pharmaceuticals Inc is Richard Koo, 79, who is the Independent Director.
Insiders trading at Amphastar Pharmaceuticals Inc
Over the last 10 years, insiders at Amphastar Pharmaceuticals Inc have traded over $72,457,295 worth of Amphastar Pharmaceuticals Inc stock and bought 66,100 units worth $921,987 . The most active insiders traders include Jack Y.Luo Mary Z. Zhang, Richard K Prins és William J Peters. On average, Amphastar Pharmaceuticals Inc executives and independent directors trade stock every 11 days with the average trade being worth of $1,459,051. The most recent stock trade was executed by Floyd F. Petersen on 5 September 2024, trading 3,000 units of AMPH stock currently worth $139,410.
What does Amphastar Pharmaceuticals Inc do?
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int
What does Amphastar Pharmaceuticals Inc's logo look like?
Complete history of Mary Luo stock trades at Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc executives and stock owners
Amphastar Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Jack Zhang,
President, Chief Executive Officer, Chief Scientific Officer, Director -
Mary Luo,
Chief Operating Officer, Chief Scientist and Chairman of the Board -
Dr. Yongfeng Zhang,
Co-founder, Pres, CEO, Chief Scientific Officer & Director -
William Peters,
Chief Financial Officer, Senior Vice President, Treasurer and President of International Medication Systems, Limited -
Dr. Ziping Luo,
Chairman, Chief Scientist & COO -
Rong Zhou,
Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc. -
William J. Peters M.B.A.,
CFO, Treasurer & Exec. VP of Fin. -
Rong Zhou,
Exec. VP of Production Center -
Jacob Liawatidewi M.B.A.,
Exec. VP of Corp. Admin. Center, Sales & Marketing and Corp. Sec. -
Diane Gerst,
Director -
Richard Prins,
Lead Independent Director -
Richard Koo,
Independent Director -
Howard Lee,
Independent Director -
Michael Zasloff,
Independent Director -
Floyd Petersen,
Independent Director -
Jacob Liawatidewi,
Senior Vice President of Sales and Marketing, Corporate Administration Center, Corporate Secretary -
Peter Langosh,
VP of Operational Improvement and VP of Internal Audit -
Tony Marrs,
Sr. VP of Regulatory Affairs and Clinical Operations -
Dan Dischner,
VP of Corp. Communications -
Stephen B. Shohet,
Director -
Gayle Deflin,
-
Physics & Chemistry Laborat...,
10% owner -
Mary Z.Zhang Jack Y. Luo,
COO,Chief Scientist & ChairmanCEO & Chief Scientific Officer -
Jason B. Shandell,
President and General Counsel -
Marilyn J. Purchase,
Corp. Exec. VP of Operations -
David Maris,
Director -
Jack Y.Luo Mary Z.Applied P...,
CEO & Chief Scientific OfficerCOO,Chief Scientist & Chairman -
Yakob Liawatidewi,
EVP CORP ADMIN CENTER